Get the Stockscreener App
57.68
3.04%
-1.81
After Hours:
57.68
Eton Pharmaceuticals Inc stock is traded at $57.68, with a volume of 502.89K.
It is down -3.04% in the last 24 hours and down -8.52% over the past month.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.
See More
Previous Close:
$59.49
Open:
$60
24h Volume:
502.89K
Relative Volume:
0.91
Market Cap:
$1.65B
Revenue:
$86.93M
Net Income/Loss:
$-1.48M
P/E Ratio:
-813.54
EPS:
-0.0709
Net Cash Flow:
$431.00K
1W Performance:
+3.93%
1M Performance:
-8.52%
6M Performance:
+141.95%
1Y Performance:
+186.40%
1-Day Range:
$57.23
$60.60
1-Week Range:
$53.60
$60.60
52-Week Range:
$14.27
$66.37
Eton Pharmaceuticals Inc Stock (ETON) Company Profile
Name
Eton Pharmaceuticals Inc
Sector
Phone
(847) 787-7361
Address
21925 W. FIELD PARKWAY, DEER PARK, IL
Compare ETON vs TAK, TEVA, HLN, ZTS, VTRS
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ETON
Eton Pharmaceuticals Inc
|
57.68 | 1.65B | 86.93M | -1.48M | 431.00K | -0.0709 |
TAK
Takeda Pharmaceutical Co Adr
|
18.86 | 60.23B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
39.19 | 45.71B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.26 | 40.72B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
71.05 | 29.36B | 9.51B | 2.64B | 2.14B | 6.0361 |
VTRS
Viatris Inc
|
17.83 | 20.48B | 14.57B | -296.50M | 1.64B | -0.259 |
Eton Pharmaceuticals Inc Stock (ETON) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-23-25 | Reiterated | H.C. Wainwright | Buy |
| Jan-10-25 | Initiated | B. Riley Securities | Buy |
| Jan-06-25 | Reiterated | H.C. Wainwright | Buy |
| Sep-04-24 | Resumed | H.C. Wainwright | Buy |
| May-06-24 | Initiated | Craig Hallum | Buy |
| Oct-14-21 | Resumed | B. Riley Securities | Buy |
| Jan-04-21 | Reiterated | H.C. Wainwright | Buy |
| Sep-20-19 | Initiated | B. Riley FBR | Buy |
| Jun-10-19 | Initiated | H.C. Wainwright | Buy |
View All
Eton Pharmaceuticals Inc Stock (ETON) Latest News
Understanding Momentum Shifts in (ETON) - Stock Traders Daily
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Eton Pharmaceuticals stock gains 6.98 percent after Q2 results - AD HOC NEWS
Is Eton Pharmaceuticals Inc (ETON) Overvalued After 7.0% Rally? - GuruFocus
Eton Pharmaceuticals (NASDAQ:ETON) Stock Price Up 5.9%Should You Buy? - MarketBeat
ETON Stock Price, Quote & Chart - ChartMill
Eton Pharmaceuticals stock reports 99 percent Q2 revenue growth - AD HOC NEWS
Eton Pharmaceutcials (ETON) Stock Price, News & Analysis - Stock Titan
Eton Pharmaceuticals stock edges higher after strong 2025 growth figures - AD HOC NEWS
Eton Pharmaceuticals stock holds steady as insider sales and recent results shape the picture - AD HOC NEWS
Eton Pharmaceuticals, Inc. (ETON) Stock Analysis: Unveiling a 24.41% Upside Potential in the Healthcare Sector - DirectorsTalk Interviews
Eton Pharmaceuticals stock holds steady as investors eye latest results - AD HOC NEWS
Liquidity Mapping Around (ETON) Price Events - Stock Traders Daily
Squarepoint Ops LLC Invests $2.16 Million in Eton Pharmaceuticals, Inc. $ETON - MarketBeat
HighTower Advisors LLC Acquires 34,484 Shares of Eton Pharmaceuticals, Inc. $ETON - MarketBeat
Hsbc Holdings PLC Makes New $1.53 Million Investment in Eton Pharmaceuticals, Inc. $ETON - MarketBeat
Eton Pharmaceuticals (ETON) Heads To Wells Fargo Conference As Fair Value Debate Stays Open - simplywall.st
Eton Pharmaceuticals Inc (NASDAQ: ETON) Share Price, ETON Stock News, ETON Share Price & Updates - Kalkine
118,249 Shares in Eton Pharmaceuticals, Inc. $ETON Purchased by Bank of New York Mellon Corp - MarketBeat
(ETON) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
ETON stock holds firm after latest quarter shows steady growth - AD HOC NEWS
Sigma Planning Corp Takes Position in Eton Pharmaceuticals, Inc. $ETON - MarketBeat
PAUL MAIER V At Eton Pharmaceuticals Executes Options Exercise, Realizing $2.84M - Benzinga
Hsbc Holdings PLC Invests $1.53 Million in Eton Pharmaceuticals, Inc. $ETON - MarketBeat
Eton Pharmaceuticals Q2 2026 Earnings: EPS Soars Past Estimates on Strong Operational ExecutionOperating Income Trends - careplusvn.com
Eton Pharmaceuticals Director Paul V. Maier Executes Stock Options and Sells Shares on August 28, 2026 - Kalkine Media
Eton Pharmaceuticals (ETON) director unloads 50K shares after option exercise - Stock Titan
34,027 Shares in Eton Pharmaceuticals, Inc. $ETON Acquired by Jefferies Financial Group Inc. - MarketBeat
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Deutsche Bank AG Purchases Shares of 26,522 Eton Pharmaceuticals, Inc. $ETON - MarketBeat
BlackRock Inc. Invests $68.63 Million in Eton Pharmaceuticals, Inc. $ETON - MarketBeat
Eton Pharmaceuticals (ETON) Slips 1.74% as Shares Pull Back Toward Key SupportPrice Action Signals - dars.gov.et
Navellier & Associates Inc. Makes New Investment in Eton Pharmaceuticals, Inc. $ETON - MarketBeat
Eton Pharmaceuticals, Inc. $ETON Stock Holdings Increased by Bank of America Corp DE - MarketBeat
1,175,951 Shares in Eton Pharmaceuticals, Inc. $ETON Purchased by Nantahala Capital Management LLC - MarketBeat
Cannell Capital LLC Acquires New Stake in Eton Pharmaceuticals, Inc. $ETON - MarketBeat
Eton Pharmaceuticals (NASDAQ:ETON) Director Sells $2,953,500.00 in Stock - MarketBeat
Eton Pharmaceuticals (NASDAQ: ETON) insider sells 50K shares - Stock Titan
Bank of Nova Scotia Acquires New Position in Eton Pharmaceuticals, Inc. $ETON - marketbeat.com
Eton leaders will hold one-on-one meetings at Wells Fargo’s Boston event - stocktitan.net
Pillsbury Lake Capital LLC Invests $14.02 Million in Eton Pharmaceuticals, Inc. $ETON - MarketBeat
Eton Pharmaceuticals to Participate at 2026 Wells Fargo Healthcare Conference - Yahoo Finance
Eton's Galzin TM And False Ad Suit Survives Dismissal Bid - Law360
Eton Pharmaceuticals Can Proceed With ‘Gluzin’ Supplement Suit - Bloomberg Law News
Insider Unloading: David Krempa Sells Options, Realizes $1.43MEton Pharmaceuticals (NASDAQ:ETON) - Benzinga
Eton Pharmaceuticals stock hits all-time high at 64.29 USD By Investing.com - Investing.com India
Eton (ETON) Financial Results: The Bottom-Line Figure Outpaces Its Comparison for the Current Session; Post-Report: Shares Move 5.94% UpDividend Cut Risk - vinanet.vn
Eton Pharmaceuticals (ETON) Returns To Profit As Valuation Debate Gets Harder To Ignore - Sahm
Eton Pharmaceuticals Inc (ETON) Stock Up 5.9% but GF Value Says Overvalued -- GF Score: 58/100 - GuruFocus
SEAN BRYNJELSEN Executes Sell Order: Offloads $6.09M In Eton Pharmaceuticals Stock - Benzinga
Eton Pharmaceuticals CEO Sean Brynjelsen sells $6.08m in stock By Investing.com - Investing.com India
Eton Pharmaceuticals Inc Stock (ETON) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.18%
0.69%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):